| Literature DB >> 17872562 |
Dermot McGovern1, Fiona Powrie.
Abstract
Exciting new results from a genetic study in humans and functional studies in mice have pinpointed interleukin 23 (IL23) and its receptor as a key pathway in the pathogenesis of inflammatory bowel disease (IBD). These findings reveal a hitherto unappreciated role for the IL23 axis in intestinal inflammation and may open new avenues for development of therapeutic strategies in IBD.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17872562 PMCID: PMC2000291 DOI: 10.1136/gut.2006.115402
Source DB: PubMed Journal: Gut ISSN: 0017-5749 Impact factor: 23.059